Literature DB >> 20672329

αVβ3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt-dependent NF-κB activation.

Alexander S Antonov1, Galina N Antonova, David H Munn, Nahid Mivechi, Rudolf Lucas, John D Catravas, Alexander D Verin.   

Abstract

Controlling macrophage responses to pathogenic stimuli is critical for prevention of and recovery from the inflammatory state associated with the pathogenesis of many diseases. The adhesion receptor αVβ3 integrin is thought to be an important receptor that regulates macrophage differentiation and macrophage responses to external signaling, but it has not been previously identified as a contributor to macrophage-related inflammation. Using an in vitro model of human blood monocytes (Mo) and monocyte-derived macrophages (MDMs) we demonstrate that αVβ3 ligation results in sustained increases of the transcription factor NF-κB DNA-binding activity, as compared with control isotype-matched IgG(1). Activation of NF-κB parallels the increase of NF-κB-dependent pro-inflammatory cytokine mRNA expression in MDMs isolated from individual donors, for example, TNF-α (8- to 28-fold), IL-1β (15- to 30-fold), IL-6 (2- to 4-fold), and IL-8 (5- to 15-fold) whereas there is more than a 10-fold decrease in IL-10 mRNA level occurs. Upon ligation of the αVβ3 receptor, treatment with TNF-α (10 ng/ml) or LPS (200 ng/ml, 1,000 EU) results in the enhanced and synergistic activation of NF-κB and LPS-induced TNF-α secretion. As additional controls, an inhibitor of αVβ3 integrin, cyclic RGD (10 µg/ml; IC(50) = 7.6 µM), attenuates the effects of αVβ3 ligation, and the natural ligand of αVβ3 integrin, vitronectin, reproduces the effects of αVβ3 activation by an immobilizing anti-αVβ3 integrin mAb. We hypothesize that αVβ3 activation can maintain chronic inflammatory processes in pathological conditions and that the loss of αVβ3 ligation will allow macrophages to escape from the inflammatory state.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20672329      PMCID: PMC3235728          DOI: 10.1002/jcp.22356

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  48 in total

Review 1.  CD36 and atherosclerosis.

Authors:  R L Silverstein; M Febbraio
Journal:  Curr Opin Lipidol       Date:  2000-10       Impact factor: 4.776

Review 2.  Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.

Authors:  Rudolf Lucas; Alexander D Verin; Stephen M Black; John D Catravas
Journal:  Biochem Pharmacol       Date:  2009-02-03       Impact factor: 5.858

3.  Atherosclerosis. Scavenging for receptors.

Authors:  M S Brown; J L Goldstein
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

Review 4.  Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.

Authors:  Weibo Cai; Xiaoyuan Chen
Journal:  Anticancer Agents Med Chem       Date:  2006-09       Impact factor: 2.505

Review 5.  Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.

Authors:  K Hamilton; E W Clair
Journal:  Expert Opin Pharmacother       Date:  2000-07       Impact factor: 3.889

Review 6.  The role of nuclear factor-kappa B in pulmonary diseases.

Authors:  J W Christman; R T Sadikot; T S Blackwell
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

7.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

Review 8.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

Review 9.  Inhibitors of integrins.

Authors:  Gordon C Tucker
Journal:  Curr Opin Pharmacol       Date:  2002-08       Impact factor: 5.547

10.  Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.

Authors:  Iina Laitinen; Antti Saraste; Eliane Weidl; Thorsten Poethko; Axel W Weber; Stephan G Nekolla; Pia Leppänen; Seppo Ylä-Herttuala; Gabriele Hölzlwimmer; Axel Walch; Irene Esposito; Hans-Jürgen Wester; Juhani Knuuti; Markus Schwaiger
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-13       Impact factor: 7.792

View more
  50 in total

1.  The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels.

Authors:  Anna K Blakney; Mark D Swartzlander; Stephanie J Bryant
Journal:  J Biomed Mater Res A       Date:  2012-03-07       Impact factor: 4.396

2.  miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium.

Authors:  Yan Huang; Melissa Crawford; Natalia Higuita-Castro; Patrick Nana-Sinkam; Samir N Ghadiali
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

3.  Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.

Authors:  Momoka Hayashida; Kei Hashimoto; Tomoko Ishikawa; Yasunori Miyamoto
Journal:  Int J Exp Pathol       Date:  2019-03-18       Impact factor: 1.925

4.  Serum vitronectin levels in patients with Behçet's disease.

Authors:  Ali Yalçındağ; Aslıhan Uzun; F Nilüfer Yalçındağ; Namık Delibaş
Journal:  Inflamm Res       Date:  2012-07-19       Impact factor: 4.575

5.  Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.

Authors:  Marco Santoro; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Eric R Molina; Danielle Wu; Waldemar Priebe; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2017-01       Impact factor: 3.845

6.  Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.

Authors:  Csilla N Felsen; Elamprakash N Savariar; Michael Whitney; Roger Y Tsien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-07       Impact factor: 5.464

7.  Intracerebral Hemorrhage Induces Inflammatory Gene Expression in Peripheral Blood: Global Transcriptional Profiling in Intracerebral Hemorrhage Patients.

Authors:  Kyle B Walsh; Xiang Zhang; Xiaoting Zhu; Eric Wohleb; Daniel Woo; Long Lu; Opeolu Adeoye
Journal:  DNA Cell Biol       Date:  2019-05-22       Impact factor: 3.311

8.  Recombinant disintegrin targets α(v) β(3) integrin and leads to mediator production.

Authors:  Lívia C A Ribeiro; Lívia C Massimino; Araceli C Durante; Aline Tansini; Ana C Urbaczek; Heloísa S Selistre-de-Araújo; Iracilda Z Carlos
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

Review 9.  Inflammasomes: a preclinical assessment of targeting in atherosclerosis.

Authors:  Jeremiah Stitham; Astrid Rodriguez-Velez; Xiangyu Zhang; Se-Jin Jeong; Babak Razani
Journal:  Expert Opin Ther Targets       Date:  2020-08-06       Impact factor: 6.902

10.  Tim-4 protects mice against lipopolysaccharide-induced endotoxic shock by suppressing the NF-κB signaling pathway.

Authors:  Liyun Xu; Peiqing Zhao; Yong Xu; Lishuang Gao; Hongxing Wang; Xiaoxia Jia; Hongxin Ma; Xiaoxong Liang; Chunxong Ma; Lifen Gao
Journal:  Lab Invest       Date:  2016-09-12       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.